Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMUM: Tacrolimus Sparing in Kidney Transplant
NCT01159080Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Apr 2010
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate sodium, tacrolimus + Wuzhi capsule in kidney transplant rejection, sponsored by Asan Medical Center. Started Apr 2010; status: completed.
02
Drugs
mycophenolate sodiumtacrolimus + Wuzhi capsule
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01159080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159080.